Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Nonexclusive licensing opportunity in HCV protease inhibitor research announced by Chiron

Oct. 6, 1997

Byk Gulden presents new gastric antisecretory agents

Oct. 2, 1997

Launch announced for new ulcerative colitis Rx

Oct. 1, 1997

Intron A/ribavirin combination for HCV: preliminary phase III results

Sep. 30, 1997

Pentoxifylline demonstrates gastroprotective effects in patient study

Sep. 30, 1997

L-Arginine for liver ischemia/reperfusion injury and transplantation

Sep. 25, 1997

Colonic prokinetic agent discovered by Janssen

Sep. 25, 1997

Octreotide acetate clinical study commences for new indication

Sep. 23, 1997

Apotex launches generic ranitidine in U.S.

Sep. 16, 1997

SciClone issued European patent for use of thymosin alpha 1 for hepatitis C

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...